Friday 11/20 Insider Buying Report: MBI, PAND

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.

So let's look at two noteworthy recent insider buys.

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.

So let's look at two noteworthy recent insider buys.

At MBIA, a filing with the SEC revealed that on Wednesday, CEO & President William C.

Fallon purchased 100,000 shares of MBI, at a cost of $6.17 each, for a total investment of $617,000.

Fallon was up about 6.3% on the purchase at the high point of today's trading session, with MBI trading as high as $6.56 in trading on Friday.

MBIA is trading up about 6.5% on the day Friday.

This buy marks the first one filed by Fallon in the past twelve months.

And also on Wednesday, Director Daniel J.

Becker purchased $449,400 worth of Pandion Therapeutics, purchasing 29,394 shares at a cost of $15.29 each.

Before this latest buy, Becker made one other buy in the past year, purchasing $13.02M shares at a cost of $18.00 a piece.

Pandion Therapeutics is trading up about 11.1% on the day Friday.

So far Becker is in the green, up about 12.2% on their buy based on today's trading high of $17.15.